istockphoto3d
Pharmaceutical Centrifuge stock illustrations
Choose from Pharmaceutical Centrifuge stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection ...
Le Lézard4d
Pioneering Progress for Rare Lives: Cell and Gene Therapy Trials in Pediatric Rare Disease Populations, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn about some of the recent scientific advances in the field of pediatrics and rare disease drug development. The featured speakers will discuss the obstacles, from ethical ...
Armed robbery in Revesby4d
Gene Therapy: One-Shot Cure for Rare Bone Disease
For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that must be delivered by ...
Business Wire1h
AceLink Therapeutics Presents Interim Results from a Phase 2 Trial of the GCS Inhibitor AL01211 in Treatment-Naïve, Classic Male Fabry Disease Patients at the WORLD Symposium 2025
AceLink Therapeutics, Inc., a clinical-stage biotech company developing next-generation oral substrate reduction therapies (SRTs), presented interim d ...
istockphoto6d
Pharmaceuticals Research stock illustrations
Choose from Pharmaceuticals Research stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection ...
Drug reverses groin hernias in male mice without surgery, shows promise in humans
By age 75, a noteworthy 50% of men develop an inguinal (groin) hernia—a bulge that results from soft tissue pushing through a ...
New treatment for hair loss shows promise — paid volunteers needed to test it out
I can tell you that VDPHL01 has a unique profile unlike current FDA-approved treatments, which are associated with cardiac ...
The Motley Fool6d
Is Vertex Pharmaceuticals a Buy Now That the FDA Approved Its New Pain Drug?
The U.S. Food and Drug Administration approved a new prescription-strength pain reliever from Vertex Pharmaceuticals on Jan. 30, 2025. Journavx is a non-opioid drug that prevents peripheral nerves ...
EurekAlert!5d
Gene therapy may be “one shot stop” for rare bone disease
For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that ...
News Medical on MSN3d
New gene therapy shows promise for lifelong treatment of hypophosphatasia
For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that must be delivered by injection three-to-six times each week.
Pharmaceutical Technology3d
Data Insights
Logistics and Supply Chain Issue: In this issue we explore logistical problems faced by distributors moving sensitive drugs across the Africa, investigate the latest IT tools revolutionising the ...
pharmaphorum5d
A history of the pharmaceutical industry
The 21st century pharmaceutical and biotech sector has come a long way from its roots in 19th century pharmacy. pharmaphorum looks at its evolution over the centuries. The roots of the ...